Elevated levels of heart type fatty acid binding protein in patients with chronic heart failure

被引：0
|
作者：
Setsuta, K
Arao, M
Miyatake, Y
Imai, T
Ogawa, T
Seino, Y
机构：
[1] Tokyo Metropolitan Komagome Hosp, Tokyo, Japan
[2] Hakujikai Mem Gen Hosp, Tokyo, Japan
[3] Nippon Med Sch, Tokyo 113, Japan
来源：
CIRCULATION | 1999年 / 100卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3421
引用
收藏
页码：649 / 649
页数：1
相关论文
共 50 条
  • [21] Serum heart type fatty acid binding protein levels are not changed in hyperthyroidism
    Ozbek, Mustafa
    Gungunes, Askin
    Sahin, Mustafa
    Ginis, Zeynep
    Ucan, Bekir
    Sayki, Muyesser
    Tutal, Esra
    Cakal, Erman
    Kuskonmaz, Serife M.
    Ozturk, Mehmet A.
    Delibasi, Tuncay
    MINERVA ENDOCRINOLOGICA, 2016, 41 (03) : 298 - 301
  • [22] Serum heart type fatty acid binding protein levels in metabolic syndrome
    Erdem Akbal
    Mustafa Özbek
    Fahri Güneş
    Ömer Akyürek
    Kemal Üreten
    Tuncay Delibaşı
    Endocrine, 2009, 36 : 433 - 437
  • [23] Serum Heart Type Fatty Acid Binding Protein Levels in Primary Hyperparathyroidism
    Ucan, Bekir
    Sahin, Mustafa
    Ozbek, Mustafa
    Caliskan, Mustafa
    Kizilgul, Muhammed
    Ozturk, Gulfer
    Ozturk, Mehmet Akif
    Cakal, Erman
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 22 (01) : 1 - 6
  • [24] Heart-type fatty acid binding protein: An important predictor of cardiac events in heart failure
    Komamura, K
    Ohta, N
    Hanatani, A
    Hirooka, K
    Yasumura, Y
    Nakatani, S
    Yamagishi, M
    Miyatake, K
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 190A - 190A
  • [25] Persistently increased serum concentrations of heart-type fatty acid-binding protein predict adverse outcomes in patients with chronic heart failure
    Niizeki, Takeshi
    Takeishi, Yasuchika
    Koyama, Yo
    Kitahara, Tatsuro
    Suzuki, Satoshi
    Kubota, Isao
    CIRCULATION, 2007, 116 (16) : 649 - 650
  • [26] Prognositic importance of elevated circulating levels of heart-type fatty acid binding protein in patients with heart failure:: comparisons with sympathetic nervous activity assessed by 123I-MIBG
    Arimoto, T
    Takeishi, Y
    Shiga, R
    Fukui, A
    Tachibana, H
    Hirono, O
    Miyamoto, T
    Kubota, I
    EUROPEAN HEART JOURNAL, 2004, 25 : 257 - 258
  • [27] Heart-type Fatty Acid Binding Protein as Predictor of Cardiac Mortality and Events in Patients with Acute Decompensated Heart Failure
    Ishino, Mitsunori
    Shishido, Tetsuro
    Funayama, Akira
    Netsu, Shunsuke
    Kiribayashi, Nobuyuki
    Arimoto, Takanori
    Takahashi, Hiroki
    Miyashita, Takehiko
    Miyamoto, Takuya
    Nitobe, Joji
    Watanabe, Tetsu
    Kubota, Isao
    CIRCULATION, 2010, 122 (21)
  • [28] A combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure
    Niizeki, T.
    Takeishi, Y.
    Arimoto, T.
    Koyama, Y.
    Kitahara, T.
    Kubota, I.
    EUROPEAN HEART JOURNAL, 2006, 27 : 17 - 17
  • [29] Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure
    Niizeki, T
    Takeishi, Y
    Arimoto, T
    Takahashi, T
    Okuyama, H
    Takabatake, N
    Nozaki, N
    Hirono, O
    Tsunoda, Y
    Shishido, T
    Takahashi, H
    Koyama, Y
    Fukao, A
    Kubota, I
    CIRCULATION JOURNAL, 2005, 69 (08) : 922 - 927
  • [30] Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure
    Sun, Yu-ping
    Wei, Chao-ping
    Ma, Shao-chun
    Zhang, Yuan-feng
    Qiao, Ling-yan
    Li, De-hua
    Shan, Ruo-bing
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2015, 65 (05) : 480 - 484
12345